12 Health Care Stocks Moving In Tuesday's Intraday Session
Portfolio Pulse from Benzinga Insights
The article reports on significant intraday movements of health care stocks, highlighting both gainers and losers. Ontrak, Fusion Pharmaceuticals, and SCWorx led the gainers with substantial increases in their stock prices, while Acutus Medical, Seelos Therapeutics, and Lantern Pharma were among the top losers. Notably, Enliven Therapeutics, Lantern Pharma, Eyenovia, and Acurx Pharmaceuticals had recent Q4 earnings reports influencing their stock movements.
March 19, 2024 | 5:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Enliven Therapeutics' stock rose by 29.19% to $16.33, with a market cap of $675.2 million. Recent Q4 earnings were released.
The stock's rise following the Q4 earnings report suggests positive investor reception to the financial results, indicating a bullish short-term outlook.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Fusion Pharmaceuticals' stock increased by 97.41% to $21.0, with a market cap of $1.5 billion.
The dramatic rise in stock price indicates strong market approval or response to company news, suggesting a positive short-term outlook.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Ontrak's stock surged 97.6% to $0.38, with a market value of $10.3 million.
The significant price surge suggests positive investor sentiment or reactions to recent company developments, potentially leading to short-term bullish behavior.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Acutus Medical's stock declined by 26.5% to $0.19, with a market value of $5.6 million.
The significant drop in stock price could reflect negative market sentiment or disappointing company news, indicating a bearish short-term trend.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90